Space-Based Genome Research Market Report 2025

The space-based genome research market size has grown rapidly in recent years. It will grow from $1.13 billion in 2024 to $1.28 billion in 2025 at a compound annual growth rate (CAGR) of 13.5%. The growth during the historic period can be attributed to the rising interest in astrobiology, an increase in human spaceflight missions, a growing need to study the effects of radiation, a heightened focus on extended space travel, and increased funding from space agencies.

The space-based genome research market size is expected to see rapid growth in the next few years. It will grow to $2.1 billion in 2029 at a compound annual growth rate (CAGR) of 13.2%. The growth in the forecast period can be attributed to the commercialization of space-based research platforms, the rise of space tourism, the expansion of private space enterprises, growing demand for remote disease diagnostics, and increased data sharing across global research networks. Major trends anticipated during the forecast period include progress in satellite miniaturization, the development of international space stations, advancements in omics technologies, compact genomic sequencing devices, and the use of cloud-based bioinformatics platforms.

Growing financial commitments to space exploration are significantly contributing to the expansion of the space-based genome research sector. These investments, made by both government bodies and private organizations, are intended to support space missions, technological advancements, and the development of infrastructure necessary for exploring outer space. As interest intensifies in deep space travel and satellite initiatives, budgets for space-related programs are increasing. This influx of funding supports the creation of essential systems that enable genetic research in extraterrestrial environments. Conducting experiments in space enhances our understanding of human biology and plays a vital role in advancing healthcare technologies tailored for space missions. For example, the Space Foundation, a U.S. based nonprofit dedicated to promoting the global space industry, reported in July 2024 that the worldwide space economy reached $570 billion in 2023, which marked an increase of 7.4 percent from the revised 2022 total of $531 billion. As a result, increased investment in space exploration is driving growth in the space-based genome research market.

Leading organizations involved in space genome research are prioritizing the development of innovative solutions like genetic research programs to advance biomedical science and maintain astronaut health during prolonged spaceflights. These initiatives aim to study DNA and gene function, particularly how space-specific conditions such as radiation and microgravity influence genetic stability and expression. A notable example occurred in September 2024 when the ISS National Laboratory, a U.S. government funded research facility, launched a five-month mission to the International Space Station. This mission supports various scientific inquiries including botanical studies, heart health investigations, and genetic research, all taking advantage of the station's unique microgravity environment. The goal is to yield discoveries that can enhance life both in space and on Earth.

In December 2023, the State of the African Diaspora (SOAD), a political organization based in Jamaica, joined forces with Spaceomix to undertake groundbreaking DNA sequencing projects in outer space. This collaboration is set to perform the first genomic sequencing beyond low Earth orbit, targeting regions such as the Moon and deep space. The goal is to push the boundaries of space-based genetic science, uncover new medical knowledge, and establish SOAD and Spaceomix as frontrunners in space biomedical research. Spaceomix, headquartered in Malta, specializes in genomics for space environments.

Major players in the space-based genome research market are The Boeing Company, Cedars-Sinai-Medical-Center, European Space Agency, Japan Aerospace Exploration Agency, Redwire Corporation, Axiom Space Inc., Fresh Gravity Inc., Nanoracks, ResearchSat, SpacePharma, Space Tango, LambdaVision, Orbit Genomics, GeneLab, BioServe, Yuri GmbH, Angiex Inc., Genes in Space, Celestial Immunity, SpaceOMIX.

North America was the largest region in the space-based genome research market in 2024. The regions covered in space-based genome research report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. The countries covered in the space-based genome research market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The rapid escalation of U.S. tariffs and the resulting trade tensions in spring 2025 are significantly impacting the professional services sector, particularly in legal, consulting, architectural, and engineering domains. Higher costs for imported technology, software licenses, office equipment, and digital infrastructure have raised operational expenses for firms reliant on global tools and platforms. International consulting projects are facing delays or cost overruns due to increased travel expenses and restricted access to foreign-sourced data and tools. Additionally, clients in manufacturing, construction, and logistics, heavily affected by tariffs are cutting back on outsourced services, squeezing demand for professional expertise. As a result, service providers are reevaluating pricing structures, expanding domestic supplier relationships, and investing in AI-driven solutions to sustain profitability and client engagement amid economic uncertainty.

Space-based genome research refers to the examination of genetic material (DNA and RNA) conducted in space or under spaceflight conditions to explore how microgravity, radiation, and other environmental factors unique to space influence gene expression, genome stability, and biological functions. This area of study is vital for understanding how space affects organisms at the molecular level, which is essential for safeguarding astronaut health, advancing space-related medical science, and enabling long-duration space missions.

The primary types of technologies used in space-based genome research include sequencing, polymerase chain reaction (PCR), microarray, and others. Sequencing involves determining the exact sequence of DNA or RNA nucleotides to interpret genetic information. Key applications include disease research, drug discovery, personalized medicine, and more, with major end-users comprising research institutions, biotechnology firms, pharmaceutical companies, and others.

The space-based genome research market research report is one of a series of new reports that provides space-based genome research market statistics, including space-based genome research industry global market size, regional shares, competitors with an space-based genome research market share, detailed space-based genome research market segments, market trends and opportunities, and any further data you may need to thrive in the space-based genome research industry. The space-based genome research market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The space-based genome research market consists of revenues earned by entities providing services such as gene expression analysis, bioinformatics, and molecular diagnostics. The market value includes the value of related goods sold by the service provider or included within the service offering. The space-based genome research market includes sales of portable DNA or RNA sequencers, space-compatible lab equipment, microfluidic devices, CRISPR-based gene-editing tools, and bioinformatics software. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.